
FDA Expands Approval of Belzutifan for Treatment of pheochromocytoma or paraganglioma
The US food and Drug Administration (FDA) has expanded the approval of Belzutifan (Welireg) to treat specific types of pheochromocytoma or paraganglioma (PPGL) in both adults and children. This represents the first FDA approval of an oral therapy for PPGL. …